MaxCyte Share News (MXCT)

MaxCyte Information

Buy MXCT Shares
Add MXCT to Watchlist
Add MXCT to Alert

Share Price Information for MaxCyte (MXCT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 380.00

Bid: 374.00

Ask: 386.00

Change: 0.00 (0.00%)

Spread: 12.00 (3.209%)

Open: 380.00

High: 380.00

Low: 380.00

Prev. Close: 380.00

Last checked at -

UK earnings, trading statements calendar - next 7 days

Wed, 03rd May 2023 14:50

Thursday 4 May
Apax Global Alpha Ltd	Q1 Results
BAE Systems PLC	Trading Statement
Cardiff Property PLC	Half Year Results
Derwent London PLC	Trading Statement
e-Therapeutics PLC	Full Year Results
Glanbia PLC	Q1 Results
IMI PLC	Trading Statement
Mondi PLC	Trading Statement
Morgan Sindall Group PLC	Trading Statement
Next PLC	Trading Statement
Rathbones Group PLC	Trading Statement
Shell PLC	Q1 Results
Spirent Communications PLC	Trading Statement
Trainline PLC	Full Year Results
Virgin Wines UK PLC	Half Year Results
Wheaton Precious Metals	Q1 Results
Friday 5 May
Eqtec PLC	Full Year Results
InterContinental Hotels Group PLC	Trading Statement
International Consolidated Airlines Group SA	Q1 Results
Monday 8 May
no events scheduled
Tuesday 9 May
Kosmos Energy Ltd	Q1 Results
Tialis Essential IT PLC	Full Year Results
Treatt PLC	Half Year Results
Wednesday 10 May
Anexo Group PLC	Full Year Results
Asos PLC	Half Year Results
Compass Group PLC	Half Year Results
Directa Plus PLC	Full Year Results
Georgia Capital PLC	Q1 Results
MaxCyte Inc	Q1 Results
Spirax-Sarco Engineering PLC	Trading Statement
Valeura Energy Inc	Q1 Results
Vertu Motors PLC	Full Year Results

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News

8 May 2019 15:58

MaxCyte begins dosing second cohort in MCY-M11 clinical trial

(Sharecast News) - Clinical-stage, cell-based therapies and life sciences company MaxCyte has initiated dosing for the second cohort of patients in its US phase 1 clinical trial with MCY-M11 - the lead, wholly-owned, non-viral mRNA-based cell therapy candidate from its CARMA platform - it announced on Wednesday.

8 May 2019 12:11

MaxCyte Dosing Second Patients Group In Phase One Cancer Drug Trial

LONDON (Alliance News) - MaxCyte Inc on Wednesday said it has begun dosing for the second cohort of patients in its phase one trial of cancer drug MCY-M11.Shares in MaxCyte were down 5.7% a

24 Apr 2019 11:37

MaxCyte Outlook Confident As Loss Narrows In 2018 On Higher Revenue

LONDON (Alliance News) - MaxCyte Inc on Wednesday said its loss narrowed in 2018 on higher annual fees from its partners as it progresses on MCY-M11 therapeutic candidate development.The a

17 Apr 2019 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 April UnileverQ1 ResultsPZ CussonsTrading SolutionsTrading 19 events

8 Apr 2019 13:58

MaxCyte Launches ExPERT Cellular Engineering Technology Platform

LONDON (Alliance News) - MaxCyte Inc on Monday announced the launch of its new ExPERT technology platform for use in cellular engineering.MaxCyte also noted that its business had produced

8 Apr 2019 08:34

MaxCyte launches new generation of cellular engineering instruments

(Sharecast News) - MaxCyte on Monday launched its ExPERT technology platform, a family of instruments that are the next generation of its complex cellular engineering technology.

1 Mar 2019 10:05

MaxCyte Inks Multi-Drug Clinical And Commercial Agreement With Kite

LONDON (Alliance News) - Biotechnology company MaxCyte Inc on Friday said it has expanded its business relationship with Kite by signing a multi-drug clinical and commercial agreement.Under

5 Feb 2019 17:45

UPDATE: MaxCyte Placing Fully Subscribed; Raises Over GBP10.0 Million (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it has raised GBP10.0 million from a placing of 5.9 million shares at 170 pence each.The life sciences company placed 5.9 million just

5 Feb 2019 10:22

MaxCyte To Raise At Least GBP10 Million For Future Growth Plans (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it plans to raise at least GBP10 million via a placing of shares in order to accelerate its growth strategy.The life sciences company no

15 Jan 2019 11:18

MaxCyte Guides For Revenue Growth And Earnings Above Expectations

LONDON (Alliance News) - MaxCyte Inc on Tuesday guided for a 19% increase in its 2018 revenue with the firm expecting its annual earnings to exceed market views.The life science company in

24 Oct 2018 16:07

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 25 OctoberGreen & Smart WoodsAlumasc GroupFriday 26 OctoberArgos Capital

10 Oct 2018 11:47

MaxCyte Begins Patient Trial Of Proposed Cancer Treatment MCY-M11

LONDON (Alliance News) - Life sciences and medicines company MaxCyte Inc on Wednesday said it has dosed the first patient in its phase I trial for MCY-M11.MCY-M11 is a mesothelin targeting

24 Sep 2018 10:18

MaxCyte Interim Revenue Rises But Loss Widens On CARMA Development

LONDON (Alliance News) - MaxCyte Inc on Monday said its loss widened in the first half of 2018 as it continued to invest in the development of its CARMA drug platform.The life sciences said

17 Sep 2018 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 18 September Ocado GroupTrading Statement DP PolandHalf Year Year Year Year

26 Jul 2018 17:50

DIRECTOR DEALINGS: Wife Of MaxCyte Non-Executive Director Buys Shares

LONDON (Alliance News) - Medical & technology company MaxCyte Inc said that Karin Johnston, wife of Non-Executive Director John Johnston, purchased 11,500 shares at a price of 240 pence per on

Latest Share Chat

MaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account